HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis.

AbstractBACKGROUND:
CC chemokines play important roles in the pathogenesis of interstitial lung diseases. Elevated CC chemokine levels have been observed in bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF).
OBJECTIVES:
We aimed to examine whether the levels of four CC chemokines, i.e. monocyte chemoattractant protein-1 (MCP-1/CCL2), macrophage inflammatory protein-1 alpha (MIP-1 alpha/CCL3), thymus- and activation-regulated chemokine (TARC/CCL17), and macrophage-derived chemokine (MDC/CCL22), in BAL fluid are predictive of the prognosis of IPF patients.
METHODS:
We compared the chemokine levels of patients alive 5 years after diagnosis and those who had died. Lung function data, CT scores, and serum markers were also compared.
RESULTS:
Among 39 patients (29 males, median age, 60 years), 19 patients (48%) died within 5 years after the diagnosis. Whereas percent vital capacity was not different, percent lung diffusion capacity for carbon monoxide was significantly higher in the surviving patients than in the nonsurviving patients (p < 0.01). Median CCL2 levels of surviving and nonsurviving patients were 154.3 (interquartile range, IQR: 67.3-381.8) and 427.2 (IQR: 329.2-1184.1) pg/ml, respectively (p < 0.02). CCL3 levels in BAL fluid did not differ between the surviving and nonsurviving patients. CCL17 was detected in BAL fluid of 7 patients, 6 of whom died within 5 years. CCL22 was detectable in BAL fluid of 10 patients, only 1 of whom survived. Serum levels of KL-6 and lactate dehydrogenase did not differ between the surviving and nonsurviving patients.
CONCLUSION:
Elevated levels of CCL2, CCL17 and CCL22 in BAL fluid might be predictive of a poor outcome in patients with IPF.
AuthorsHiromi Shinoda, Sadatomo Tasaka, Seitaro Fujishima, Wakako Yamasawa, Keisuke Miyamoto, Yasushi Nakano, Hirofumi Kamata, Naoki Hasegawa, Akitoshi Ishizaka
JournalRespiration; international review of thoracic diseases (Respiration) Vol. 78 Issue 3 Pg. 285-92 ( 2009) ISSN: 1423-0356 [Electronic] Switzerland
PMID19270434 (Publication Type: Journal Article)
Copyright(c) 2009 S. Karger AG, Basel.
Chemical References
  • Chemokines, CC
Topics
  • Aged
  • Bronchoalveolar Lavage Fluid (chemistry)
  • Chemokines, CC (analysis, metabolism)
  • Female
  • Humans
  • Idiopathic Pulmonary Fibrosis (metabolism, mortality)
  • Japan (epidemiology)
  • Male
  • Middle Aged
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: